DH logo

Definitive Healthcare (DH) Company Overview

Profile

Full Name:

Definitive Healthcare Corp.

Sector:

Healthcare

Country:

United States

IPO:

September 15, 2021

Indexes:

Not included

Description:

Definitive Healthcare provides data and analytics for the healthcare industry. They offer insights on hospitals, physicians, and other healthcare providers, helping businesses make informed decisions. Their platform supports market research, sales, and marketing efforts, enabling clients to understand the healthcare landscape better.

Key Details

Price

$5.04

Annual Revenue

$251.41 M(+12.92% YoY)

Annual EPS

-$1.79(-2457.14% YoY)

Annual ROE

-15.10%

Beta

1.31

Events Calendar

Earnings

Next earnings date:

Feb 28, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Feb 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 16, 25 Needham
Hold
Jan 13, 25 Barclays
Underweight
Dec 20, 24 Stephens & Co.
Equal-Weight
Nov 8, 24 Needham
Hold
Sep 17, 24 BTIG
Buy
Aug 9, 24 Deutsche Bank
Hold
Aug 7, 24 Barclays
Equal-Weight
Aug 7, 24 Baird
Neutral
Aug 6, 24 Needham
Hold
Aug 6, 24 Morgan Stanley
Equal-Weight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

A Dive Into Definitive Healthcare
A Dive Into Definitive Healthcare
A Dive Into Definitive Healthcare
DH
seekingalpha.comFebruary 4, 2025

Definitive Healthcare trades at a discount to the overall market based on P/E, and a new CEO with a focus on simplifying operations but faces declining profits and revenues. The company also has recently announced a new $100 billion stock buyback authorization and is seeing significant unlevered free cash flow. A first look at Definitive Healthcare follows in the paragraphs below.

Definitive Healthcare (DH) Moves to Buy: Rationale Behind the Upgrade
Definitive Healthcare (DH) Moves to Buy: Rationale Behind the Upgrade
Definitive Healthcare (DH) Moves to Buy: Rationale Behind the Upgrade
DH
zacks.comJanuary 21, 2025

Definitive Healthcare (DH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Definitive Healthcare to Present at the 27th Annual Needham Growth Conference
Definitive Healthcare to Present at the 27th Annual Needham Growth Conference
Definitive Healthcare to Present at the 27th Annual Needham Growth Conference
DH
globenewswire.comJanuary 8, 2025

FRAMINGHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Kevin Coop, and its Chief Financial Officer, Rick Booth, will present at the 27th Annual Needham Growth Conference.

Surging Earnings Estimates Signal Upside for Definitive Healthcare (DH) Stock
Surging Earnings Estimates Signal Upside for Definitive Healthcare (DH) Stock
Surging Earnings Estimates Signal Upside for Definitive Healthcare (DH) Stock
DH
zacks.comNovember 25, 2024

Definitive Healthcare (DH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Definitive Healthcare Corp. (DH)) Q3 2024 Earnings Call Transcript
Definitive Healthcare Corp. (DH)) Q3 2024 Earnings Call Transcript
Definitive Healthcare Corp. (DH)) Q3 2024 Earnings Call Transcript
DH
seekingalpha.comNovember 10, 2024

Definitive Healthcare Corp. (NASDAQ:DH ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Matt Ruderman - Investor Relations Kevin Coop - Chief Executive Officer Richard Booth - Chief Financial Officer Conference Call Participants Jenny Shen - BTIG George Hill - Deutsche Bank Anna Kruszenski - Barclays Bank Operator Welcome to Definitive Healthcare's Q3 2024 Earnings Call. Later we will conduct a question-and-answer session.

Definitive Healthcare Corp. (DH) Beats Q3 Earnings and Revenue Estimates
Definitive Healthcare Corp. (DH) Beats Q3 Earnings and Revenue Estimates
Definitive Healthcare Corp. (DH) Beats Q3 Earnings and Revenue Estimates
DH
zacks.comNovember 7, 2024

Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.09 per share a year ago.

Definitive Healthcare launches predictive analytics solution that empowers healthcare organizations to prepare and plan for future market conditions
Definitive Healthcare launches predictive analytics solution that empowers healthcare organizations to prepare and plan for future market conditions
Definitive Healthcare launches predictive analytics solution that empowers healthcare organizations to prepare and plan for future market conditions
DH
globenewswire.comOctober 10, 2024

Market Forecast equips providers with three, five, and 10-year market trend projections to strengthen strategic planning around future demand and growth opportunities Market Forecast equips providers with three, five, and 10-year market trend projections to strengthen strategic planning around future demand and growth opportunities

Irenic Capital Management LP's Strategic Acquisition in Definitive Healthcare Corp
Irenic Capital Management LP's Strategic Acquisition in Definitive Healthcare Corp
Irenic Capital Management LP's Strategic Acquisition in Definitive Healthcare Corp
DH
gurufocus.comOctober 4, 2024

On September 30, 2024, Irenic Capital Management LP (Trades, Portfolio) made a significant addition to its investment portfolio by acquiring 6,413,185 shares of Definitive Healthcare Corp (DH, Financial). This transaction, executed at a price of $4.47 per share, marks a substantial increase in the firm's holdings in the healthcare sector, reflecting a strategic move to bolster its position in this industry.

Definitive Healthcare launches powerful consumer analytics and activation solution to more industries with Population Intelligence expansion
Definitive Healthcare launches powerful consumer analytics and activation solution to more industries with Population Intelligence expansion
Definitive Healthcare launches powerful consumer analytics and activation solution to more industries with Population Intelligence expansion
DH
globenewswire.comAugust 27, 2024

Population Intelligence empowers businesses to improve marketing campaigns and digital advertising performance with combined clinical and consumer insights Population Intelligence empowers businesses to improve marketing campaigns and digital advertising performance with combined clinical and consumer insights

Definitive Healthcare: Poor Near-Term Outlook, But New CEO May Change Things
Definitive Healthcare: Poor Near-Term Outlook, But New CEO May Change Things
Definitive Healthcare: Poor Near-Term Outlook, But New CEO May Change Things
DH
seekingalpha.comAugust 19, 2024

DH remains a hold rating due to its poor near-term outlook and recent results. 2Q24 results show decelerating growth, client count decline, and an elongated sales cycle. New CEO Kevin Coop could be a game changer, but there is no reason to invest in DH at this point.

FAQ

  • What is the ticker symbol for Definitive Healthcare?
  • Does Definitive Healthcare pay dividends?
  • What sector is Definitive Healthcare in?
  • What industry is Definitive Healthcare in?
  • What country is Definitive Healthcare based in?
  • When did Definitive Healthcare go public?
  • Is Definitive Healthcare in the S&P 500?
  • Is Definitive Healthcare in the NASDAQ 100?
  • Is Definitive Healthcare in the Dow Jones?
  • When was Definitive Healthcare's last earnings report?
  • When does Definitive Healthcare report earnings?
  • Should I buy Definitive Healthcare stock now?

What is the ticker symbol for Definitive Healthcare?

The ticker symbol for Definitive Healthcare is NASDAQ:DH

Does Definitive Healthcare pay dividends?

No, Definitive Healthcare does not pay dividends

What sector is Definitive Healthcare in?

Definitive Healthcare is in the Healthcare sector

What industry is Definitive Healthcare in?

Definitive Healthcare is in the Health Information Services industry

What country is Definitive Healthcare based in?

Definitive Healthcare is headquartered in United States

When did Definitive Healthcare go public?

Definitive Healthcare's initial public offering (IPO) was on September 15, 2021

Is Definitive Healthcare in the S&P 500?

No, Definitive Healthcare is not included in the S&P 500 index

Is Definitive Healthcare in the NASDAQ 100?

No, Definitive Healthcare is not included in the NASDAQ 100 index

Is Definitive Healthcare in the Dow Jones?

No, Definitive Healthcare is not included in the Dow Jones index

When was Definitive Healthcare's last earnings report?

Definitive Healthcare's most recent earnings report was on Nov 7, 2024

When does Definitive Healthcare report earnings?

The next expected earnings date for Definitive Healthcare is Feb 28, 2025

Should I buy Definitive Healthcare stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions